AFP and seminoma: In consequence, our data support the hypothesis that surveillance might be the adequate treatment of choice for seminoma CSIS patients with mildly elevated AFP since 75% of patients with undulant AFP values did not experience relapse and had most likely elevated AFP due to other non-malignant reasons (Table 1).